KALY- Kali-Extracts Announces New Analyst Report Speculating $0.05 PPS Following Recent Biopharmaceutical Cannabis Extract Updates
The report speculates a potential KALY price per share of $0.05.
Read More
Category: Company Reports
ScottsMiracle-Gro Revises Full-Year Guidance for Fiscal 2019;Â Sales Outlook Improves for U.S. Consumer and Hawthorne
Company-wide sales now expected to improve 13-14% from 2018.
Read More
Aleafia Health Reports 2018 Fiscal Year-end Results, Provides Corporate Update
Aleafia Health has filed today its audited consolidated financial statements and related management’s discussion and analysis, both of which are available on Aleafia Health’s profile at www.SEDAR.com.
Read More
GW Pharmaceuticals plc to Report Financial Results and Operational Progress for the Period Ending March 31, 2019 and Host Conference Call on May 6, 2019
Conference call information will be provided in the financial results press release.
Read More
Hemp, Inc. Releases its 2018 Annual Report Showing Massive Revenue Increase Over Previous Year
Hemp, Inc. showed over an 1,800% increase in sales from previous year 2017.
Read MoreGET LISTED
